Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America

Zinger Key Points
  • CannaPharmaRx's cutting-edge cannabis production reaches Latin America through ICAN's distribution network.
  • Strategic agreement targets major growth in Mexico and Panama's cannabis sectors.

Cannapharmarx Inc CPMD has entered into a multi-year supply agreement with ICAN Green S.A. de C.V., part of ICAN Investing Group LLC. This partnership aims to establish a robust distribution network across Latin America, with a keen focus on Mexico and Panama.

CannaPharmaRx, recognized for its cutting-edge cannabis production facilities, will supply ICAN with a range of cannabis products. This agreement mandates ICAN to meet minimum annual purchase requirements, underscoring the deal’s magnitude for both entities.

ICAN, a pioneering force in the Latin American cannabis sector, specializes in the education, research, and development of cannabis-based medications. Notably, it stands as the first company to legally import THC API into Mexico, marking a historical milestone in the region’s cannabis landscape.

CEOs Comment On Partnership

Dean Medwid, CEO of CannaPharmaRx, expressed enthusiasm about the partnership, calling it a pivotal step towards the company’s international expansion strategy. “By securing this strategic partnership with ICAN, we continue to evolve our systematic international expansion strategy that will create diversity of revenue and allow us to introduce our high-quality products to an expanding global audience.”

Erick Ponce, CEO of ICAN, mirrored this sentiment, emphasizing the partnership’s role in transforming healthcare in Latin America through innovative cannabis solutions. “Our collaboration with CannaPharmaRx marks a crucial advancement in our journey to revolutionize patient care with high-quality, research-driven cannabis products,” Ponce remarked.

With a commitment to utilizing the latest technology in power generation, CannaPharmaRx aims to establish itself as a low-cost cannabis producer, contributing significantly to the industry’s growth and accessibility in Latin America and beyond.

CPMD Price Action

CPMD's shares were trading at $0.013 per share at the time of this writing around 9:30 AM ET Tuesday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisDean MedwidErick PonceiCanICAN Green S.A. de C.V.ICAN Investing Group LLCLatin America cannabis
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.